Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium.

Li M, Hurren R, Zastawny RL, Ling V, Buick RN.

Br J Cancer. 1999 Jun;80(8):1123-31.

2.

Syndecan-1 is up-regulated in ras-transformed intestinal epithelial cells.

Wong ZM, Choo B, Li M, Carey DJ, Cano-Gauci DF, Buick RN.

Br J Cancer. 1998 Mar;77(6):890-6.

3.

Transcriptional regulation of OCI-5/Glypican 3: elongation control of confluence-dependent induction.

Li M, Pullano R, Yang HL, Lee HK, Miyamoto NG, Filmus J, Buick RN.

Oncogene. 1997 Sep 25;15(13):1535-44.

4.

Expression of OCI-5/glypican 3 during intestinal morphogenesis: regulation by cell shape in intestinal epithelial cells.

Li M, Choo B, Wong ZM, Filmus J, Buick RN.

Exp Cell Res. 1997 Aug 25;235(1):3-12.

PMID:
9281346
5.

Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization.

Shen T, Sonoda G, Hamid J, Li M, Filmus J, Buick RN, Testa JR.

Mamm Genome. 1997 Jan;8(1):72. No abstract available.

PMID:
9021160
7.

Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.

Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.

Infect Immun. 1994 Nov;62(11):5040-7.

8.

Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells.

Jamal HH, Cano-Gauci DF, Buick RN, Filmus J.

Oncogene. 1994 Feb;9(2):417-23.

PMID:
7507229
9.

In vitro cDNA amplification from individual intestinal crypts: a novel approach to the study of differential gene expression along the crypt-villus axis.

Cano-Gauci DF, Lualdi JC, Ouellette AJ, Brady G, Iscove NN, Buick RN.

Exp Cell Res. 1993 Oct;208(2):344-9.

PMID:
7690709
12.

The role of epidermal growth factor receptors in breast cancer.

Buick RN, Filmus J, Church JG.

Cancer Treat Res. 1991;53:159-70. Review. No abstract available.

PMID:
1672075
13.

Studies of EGF-mediated growth control and signal transduction using the MDA-MB-468 human breast cancer cell line.

Buick RN, Filmus J, Church J.

Prog Clin Biol Res. 1990;354A:179-91. Review. No abstract available.

PMID:
2247487
14.

Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution.

Grenman R, Burk D, Virolainen E, Buick RN, Church J, Schwartz DR, Carey TE.

Int J Cancer. 1989 Jul 15;44(1):131-6.

PMID:
2744882
17.
18.

Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene.

Kovnat A, Buick RN, Choo B, De Harven E, Kopelyan I, Trent JM, Tannock IF.

Cancer Res. 1988 Sep 1;48(17):4993-5000.

19.
21.

Activated H-ras transforms rat intestinal epithelial cells with expression of alpha-TGF.

Buick RN, Filmus J, Quaroni A.

Exp Cell Res. 1987 Jun;170(2):300-9.

PMID:
3474152
22.
23.
24.

A cell line from a human ovarian carcinoma with amplification of the K-ras gene.

Filmus J, Trent JM, Pullano R, Buick RN.

Cancer Res. 1986 Oct;46(10):5179-82.

25.

Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line.

Baumal R, Law J, Buick RN, Kahn H, Yeger H, Sheldon K, Colgan T, Marks A.

Cancer Res. 1986 Aug;46(8):3994-4000.

26.

The use of restriction fragment polymorphisms to identify the cell line MCF-7.

Graham KA, Trent JM, Osborne CK, McGrath CM, Minden MD, Buick RN.

Breast Cancer Res Treat. 1986;8(1):29-34.

PMID:
3790748
27.
28.

Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line.

Filmus J, Pollak MN, Cairncross JG, Buick RN.

Biochem Biophys Res Commun. 1985 Aug 30;131(1):207-15.

PMID:
2994648
29.

Comparative properties of five human ovarian adenocarcinoma cell lines.

Buick RN, Pullano R, Trent JM.

Cancer Res. 1985 Aug;45(8):3668-76.

30.

Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7.

Graham KA, Richardson CL, Minden MD, Trent JM, Buick RN.

Cancer Res. 1985 May;45(5):2201-5.

31.
32.

Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

Bell DR, Gerlach JH, Kartner N, Buick RN, Ling V.

J Clin Oncol. 1985 Mar;3(3):311-5.

PMID:
2857774
33.
34.

Generation of clonal variants in a human ovarian carcinoma studied by chromosome banding analysis.

Trent JM, Thompson FH, Buick RN.

Cancer Genet Cytogenet. 1985 Jan 1;14(1-2):153-61.

PMID:
3965120
35.

Perspectives on clonogenic tumor cells, stem cells, and oncogenes.

Buick RN, Pollak MN.

Cancer Res. 1984 Nov;44(11):4909-18. Review. No abstract available.

36.

Comparison of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics.

Kovnat A, Buick RN, Connolly JG, Jewett MA, Keresteci AG, Tannock IF.

Cancer Res. 1984 Jun;44(6):2530-3.

37.

Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma.

Trent JM, Buick RN, Olson S, Horns RC Jr, Schimke RT.

J Clin Oncol. 1984 Jan;2(1):8-15.

PMID:
6699660
38.

Cell heterogeneity in human ovarian carcinoma.

Buick RN.

J Cell Physiol Suppl. 1984;3:117-22. Review. No abstract available.

PMID:
6378933
39.

Therapeutic implications of a stem cell model for human breast cancer: a hypothesis.

Selby P, Bizzari JP, Buick RN.

Cancer Treat Rep. 1983 Jul-Aug;67(7-8):659-63.

PMID:
6871882
40.

Tumor progression studied by analysis of cellular features of serial ascitic ovarian carcinoma tumors.

Mackillop WJ, Trent JM, Stewart SS, Buick RN.

Cancer Res. 1983 Feb;43(2):874-8.

PMID:
6848199
41.

Cellular specificity of NB70K, a putative human ovarian tumor antigen.

Bizzari JP, Mackillop WJ, Buick RN.

Cancer Res. 1983 Feb;43(2):864-7.

PMID:
6336660
42.

A critical appraisal of the "human tumor stem-cell assay".

Selby P, Buick RN, Tannock I.

N Engl J Med. 1983 Jan 20;308(3):129-34. No abstract available.

PMID:
6336820
43.

A stem cell model of human tumor growth: implications for tumor cell clonogenic assays.

Mackillop WJ, Ciampi A, Till JE, Buick RN.

J Natl Cancer Inst. 1983 Jan;70(1):9-16.

PMID:
6571928
44.

Density/volume analysis in the study of cellular heterogeneity in human ovarian carcinoma.

Mackillop WJ, Stewart SS, Buick RN.

Br J Cancer. 1982 Jun;45(6):812-20.

45.
46.

Self-renewal capacity of leukemic blast progenitor cells.

Buick RN, Chang LJ, Messner HA, Curtis JE, McCulloch EA.

Cancer Res. 1981 Nov;41(11 Pt 2):4849-52.

47.
48.

The heritable nature of clonal characteristics in acute myeloblastic leukemia.

McCulloch EA, Buick RN, Curtis JE, Messner HA, Senn JS.

Blood. 1981 Jul;58(1):105-9.

49.
50.

A comparison of human tumour-cell clonogenicity in methylcellulose and agar culture.

Buick RN, Fry SE.

Br J Cancer. 1980 Dec;42(6):933-6. No abstract available.

Supplemental Content

Loading ...
Support Center